Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
305
NCT01898715
Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 13, 2013
Completion: Oct 17, 2017
NCT02804178
A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Phase: Phase 2
Start: May 18, 2016
Completion: Aug 17, 2017
NCT02865915
MLE4901 vs. Placebo for the Treatment of PCOS
Start: Jul 31, 2016
Completion: Sep 30, 2017
NCT03053271
A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome
Start: Apr 13, 2017
Completion: Aug 12, 2019
NCT03669549
Nevanimibe HCl for the Treatment of Classic CAH
Start: Jul 11, 2018
Completion: Jul 12, 2020
NCT03790865
Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
Phase: Phase 2/3
Start: Mar 25, 2019
Completion: May 25, 2020